6453-88-9 Usage
General Description
N-(2-bromoethyl)benzenesulfonamide, also known as 2-Bromoethylbenzenesulfonamide, is a chemical compound primarily used as an intermediate in the synthesis of pharmaceuticals and pesticides. It is a white solid that is soluble in organic solvents and has a molecular weight of 255.09 g/mol. N-(2-bromoethyl)benzenesulfonamide is known for its ability to function as a sulfonamide, which is a class of compounds commonly used as antibacterial agents and in the treatment of various diseases. It is important to handle N-(2-bromoethyl)benzenesulfonamide with caution, as it may be harmful if ingested, inhaled, or comes into contact with the skin. Additionally, it is advisable to wear protective equipment when working with this chemical to prevent any potential adverse effects on health.
Check Digit Verification of cas no
The CAS Registry Mumber 6453-88-9 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,4,5 and 3 respectively; the second part has 2 digits, 8 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 6453-88:
(6*6)+(5*4)+(4*5)+(3*3)+(2*8)+(1*8)=109
109 % 10 = 9
So 6453-88-9 is a valid CAS Registry Number.
6453-88-9Relevant articles and documents
PROPHYLACTIC AND/OR THERAPEUTIC AGENT FOR DISEASES ASSOCIATED WITH AMPA RECEPTORS
-
Paragraph 0042; 0061; 0062, (2019/11/28)
This prophylactic and/or therapeutic agent for diseases associated with AMPA receptors contains a compound represented by formula (I), or a pharmaceutically acceptable salt or solvate thereof. (In the formula, A and Z independently represent CO, SO or SO
In vivo AMPA receptors in the brain imaging method of primates, program, and screening method
-
Paragraph 0099, (2018/06/30)
This imaging method of AMPA receptors in the brain of primate organisms involves a step in which a substance which is administered to the primate organism and which selectively bonds to AMPA receptors in the brain of the primate organism and has a radiola
OXAZOLE AND THIAZOLE DERIVATIVES AND THEIR USES 2
-
Page/Page column 46, (2008/12/08)
Compounds of formula (I): wherein A, X, R1, R2, R3, R4, R5, R6 and R8 are as defined in the Specification are useful in the treatment of diseases where enhanced M3 receptor activ
